IL37 and neoplasm: These observations also explain the pro- or antitumoral effects described for IL-23 on NK cells (29, 40–42, 47, 48), which may critically depend on the composition of the tumor microenvironment, in particular, the presence of other cytokines that regulate NK cell effector functions.